Best regimens for treating chemo ‐naïve incurable squamous non‐small cell lung cancer with a programmed death‐ligand 1 tumor proportion score of 1%–49%: A network meta‐analysis
ConclusionsThe combination therapies, which were the platinum regimen + Pemb and the platinum regimen + Niv + Ipi, rather than ICI monotherapy were effective first-line agents for treating squamous NSCLC with low PD-L1 levels.
Source: Thoracic Cancer - Category: Cancer & Oncology Authors: Nobuhiko Fukuda,
Nobuyuki Horita,
Ho Namkoong,
Ayami Kaneko,
Kohei Somekawa,
Yoichi Tagami,
Keisuke Watanabe,
Yu Hara,
Nobuaki Kobayashi,
Takeshi Kaneko Tags: ORIGINAL ARTICLE Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Lung Cancer | Non-Small Cell Lung Cancer | Pathology | Statistics | Study | Yervoy